North America Infusion Devices Market Outlook for Connected Pump Systems 2031

The North America Infusion Devices Market is gaining traction as healthcare delivery expands beyond conventional inpatient settings. Portable and ambulatory infusion devices are supporting selected treatments in outpatient clinics and patients' homes, helping meet demand for flexible care options.

The Infusion
Devices Market was valued at US$ 13.73 billion in 2023 and is
projected to reach US$ 23.08 billion by 2031, registering a CAGR of
6.7% during 2023–2031. Infusion devices are medical systems designed to
deliver fluids, medications, nutrients, blood products, and other prescribed
substances into a patient's body at controlled rates. These devices are widely
used in hospitals, clinics, ambulatory care centers, and home healthcare
settings. Growing demand for precise medication administration, increasing
prevalence of chronic diseases, and technological advances in infusion pumps
and related delivery systems are supporting market development.

What is driving the Infusion Devices Market?

The growing need for controlled and accurate medication
delivery across acute and chronic care settings is a major factor driving the
Infusion Devices Market.

Infusion devices play an important role in administering
medications and fluids to patients who require intravenous therapy or other
forms of controlled delivery. The increasing burden of cancer, diabetes,
cardiovascular conditions, and other chronic diseases is contributing to demand
for infusion technologies across hospitals and outpatient facilities. Many
treatments require carefully managed delivery rates, making reliable infusion
systems essential to clinical workflows.

Get a Sample PDF- https://www.theinsightpartners.com/sample/TIPRE00039332

The expansion of specialized medical treatments is another
important growth driver. Chemotherapy, antibiotic therapy, pain management,
hydration, and nutritional support may require infusion devices suited to specific
clinical requirements. The growing use of biologic medicines and complex
treatment regimens is also increasing the need for devices that support
controlled administration and dependable operation.

The shift toward home-based treatment is further influencing
the market. Portable infusion pumps and ambulatory systems can enable selected
therapies to be administered outside hospitals under appropriate clinical
supervision. These devices may help reduce the need for prolonged hospital
stays and support treatment convenience when home infusion is suitable for the
patient.

Technological improvements are also encouraging adoption.
Modern infusion systems increasingly incorporate programmable settings, dose
libraries, alarms, occlusion detection, and connectivity features. These
capabilities can support medication safety and help clinicians monitor device
performance during treatment.

Which region leads the Infusion Devices Market?

North America represents an important market for infusion
devices, supported by advanced healthcare infrastructure, substantial
healthcare expenditure, and the adoption of sophisticated medication-delivery
technologies.

The United States contributes significantly to regional
demand through its extensive hospital network, cancer treatment centers,
outpatient facilities, and home healthcare services. Healthcare providers
require infusion systems for a wide range of therapies, including medication
administration, fluid replacement, and specialized treatment protocols.
Continued investment in patient safety and clinical technology also supports
demand for modern infusion equipment.

Europe is another important market, supported by established
healthcare systems, growing demand for advanced medical devices, and the
presence of medical technology manufacturers. Hospitals and specialty clinics
are investing in infusion systems that support reliable operation, efficient
workflows, and appropriate medication-delivery controls.

Asia Pacific offers additional growth opportunities as
healthcare infrastructure expands and access to specialized treatment improves.
Rising demand for cancer care, diabetes management, and hospital-based
therapies is increasing the need for infusion equipment. Investments in
healthcare facilities and the development of domestic medical-device
manufacturing capabilities may further support regional growth.

Latin America and the Middle East and Africa also present
opportunities as healthcare providers upgrade medical infrastructure and expand
access to specialized treatment. However, purchasing budgets, distribution
networks, regulatory requirements, and access to trained personnel can
influence adoption across individual markets.

Which segment leads the Infusion Devices Market?

Infusion pumps represent a central product category
because they enable controlled delivery of medications and fluids across a
broad range of clinical applications.

The Infusion Devices Market can be segmented by product
type, application, end user, and distribution channel. Major product categories
include infusion pumps, infusion sets, accessories, and related administration
systems. The requirements for each product vary according to the medication
being delivered, the treatment setting, and the degree of control required.

Volumetric infusion pumps are used to deliver specified
volumes of fluids over defined periods, while syringe pumps provide controlled
administration from a syringe and are commonly used when precise, low-volume
delivery is needed. Ambulatory infusion pumps support selected therapies
outside traditional hospital settings, while specialized systems are designed
for applications such as insulin administration.

Applications include oncology, diabetes care, pain
management, hydration, antibiotic therapy, and nutritional support. The diversity
of these applications creates demand for devices with different delivery
capacities, programming functions, and safety features.

Hospitals remain important end users because they administer
a wide range of intravenous medications and fluids. Ambulatory surgical
centers, specialty clinics, home healthcare providers, and long-term care
facilities also contribute to market demand. The expansion of outpatient
treatment and home infusion services is encouraging manufacturers to develop
portable systems with intuitive controls and appropriate safety mechanisms.

Which companies are prominent in the Infusion Devices
Market?

Key industry participants profiled in the Infusion
Devices Market include:

• B.
  Braun SE


• Terumo
  Corporation


• Medtronic
  plc


• Moog,
  Inc.


• Baxter
  International Inc.


• ICU
  Medical, Inc.


• Nipro
  Corporation


• Tandem
  Diabetes Care, Inc.


• Fresenius
  Kabi AG


• BPL
  Medical Technologies Pvt. Ltd.

Competition in the Infusion Devices Market is influenced by
device reliability, delivery accuracy, safety features, ease of use, regulatory
compliance, and compatibility with healthcare workflows. Manufacturers are
developing systems intended to support different treatment requirements while
helping clinicians manage medication administration efficiently.

Product innovation increasingly focuses on smart infusion
pumps, integrated dose-error reduction software, enhanced alarm systems, and
connectivity with hospital information systems. These capabilities can help
healthcare facilities standardize medication-delivery processes and improve
visibility into infusion activity.

Manufacturers are also working to improve portability, user
interfaces, battery performance, and maintenance requirements. These features
are particularly relevant in ambulatory and home healthcare settings, where
devices may need to operate for extended periods with limited direct
supervision.

Strategic partnerships, product development initiatives, and
expansion of distribution networks also influence competition. Manufacturers
must balance technological capabilities with affordability, training
requirements, service support, and the needs of healthcare facilities across
different markets.

What is changing in the Infusion Devices Market in 2026?

In 2026, infusion device development is increasingly
focused on medication safety, connected monitoring, automation, and the
expansion of treatment beyond hospital settings.

Smart infusion pumps are becoming an important area of
technological development. Features such as drug libraries, programmable
limits, and dose-error reduction software are designed to help clinicians
identify certain programming errors and support safer medication
administration. Their effectiveness depends on appropriate configuration,
maintenance, staff training, and adherence to clinical protocols.

Connectivity is another important trend. Integration with
electronic health records and hospital information systems can support
documentation, data sharing, and workflow coordination. Connected devices also
create requirements for cybersecurity, interoperability, and dependable network
performance.

Portable and ambulatory infusion systems are gaining
attention as healthcare providers consider ways to deliver suitable treatments
in outpatient and home environments. Compact designs and improved battery capabilities
can support mobility, although patient eligibility, treatment complexity, and
monitoring requirements determine whether home infusion is appropriate.

Manufacturers are also emphasizing usability and alarm
management. Clear interfaces, intuitive programming, and effective alerts can
help clinicians operate devices in busy healthcare environments. At the same
time, device safety, reliability, and regulatory compliance remain essential
considerations as new features are introduced.

What are the major investment opportunities in the
Infusion Devices Market?

Investment opportunities are emerging in smart infusion
pumps, ambulatory delivery systems, connected medication management, and
advanced infusion safety technologies.

Smart infusion systems represent an important opportunity
for manufacturers developing technologies that combine controlled delivery with
software-based safety features. Improvements in programming interfaces, dose
libraries, monitoring capabilities, and interoperability may support demand
from hospitals seeking to modernize medication administration.

Ambulatory and home infusion technologies provide another
area for investment. As appropriate treatments move into outpatient
environments, healthcare providers may require portable systems that are
reliable, easy to operate, and suitable for the prescribed therapy. Devices
designed around patient mobility and practical home-use requirements can help
address this demand.

Connected healthcare infrastructure also creates
opportunities for companies developing software and integration solutions for
infusion devices. Technologies that support data exchange, treatment
documentation, and equipment monitoring may help hospitals coordinate care and
manage device utilization more efficiently.

Emerging healthcare markets offer additional opportunities
as hospitals expand capacity and invest in modern medical equipment. However,
market participants must account for product approval requirements,
manufacturing costs, training needs, service infrastructure, and the importance
of preventing medication-delivery errors.

Through 2031, increasing demand for controlled drug
administration, continued advances in infusion technology, and the expansion of
outpatient and home-based treatment are expected to support the growth of the
global Infusion Devices Market.

Related Reports:

North
America Infusion Devices Market Growth and Forecast by 2031

Diabetes
Monitoring Devices Market Size, Demand & Growth by 2034

About Us –

The Insight Partners provides comprehensive syndicated and
tailored market research services in the healthcare, technology, and industrial
domains. Renowned for delivering strategic intelligence and practical insights,
the firm empowers businesses to remain competitive in ever-evolving global
markets.

Contact Us:

Contact Person: Ankit Mathur

E-mail: ankit.mathur@theinsightpartners.com  

Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish